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Objective. To investigate the relationship between coping and atherothrombotic biomarkers of an increased cardiovascular disease
(CVD) risk in the elderly. Methods. We studied 136 elderly caregiving and noncaregiving men and women who completed the
Ways of Coping Checklist to assess problem-focused coping, seeking social support (SSS), blamed self, wishful thinking, and
avoidance coping. They had circulating levels of 12 biomarkers measured. We also probed for potential mediator and moderator
variables (chronic stress, affect, health behavior, autonomic activity) for the relation between coping and biomarkers. Results.
After controlling for demographic and CVD risk factors, greater use of SSS was associated with elevated levels of serum amyloid
A (P = 0.001), C-reactive protein (CRP) (P = 0.002), vascular cellular adhesion molecule (VCAM)-1 (P = 0.021), and D-
dimer (P = 0.032). There were several moderator effects. For instance, greater use of SSS was associated with elevated VCAM-1
(P < 0.001) and CRP (P = 0.001) levels in subjects with low levels of perceived social support and positive affect, respectively.
The other coping styles were not significantly associated with any biomarker. Conclusions. Greater use of SSS might compromise
cardiovascular health through atherothrombotic mechanisms, including elevated inflammation (i.e., serum amyloid A, CRP,
VCAM-1) and coagulation (i.e., D-dimer) activity. Moderating variables need to be considered in this relationship.
1. Introduction
Coping is undoubtedly one of the most extensively
researched concepts in behavioral medicine. How people
react to environmental challenges, as well as health-related
hardship to reduce psychological distress, is a function of the
type of the stressor and of an individual’s coping styles which
may include thoughts, emotions, and behaviors [1]; the
resulting physiological changes may favourably or adversely
impact health [2]. However, compared to the literature about
the importance of coping for psychological health outcomes,
research on coping styles and biological indicators of health
is small [3].
Coping styles can be assessed in many ways [4]. Fre-
quently used self-rating tools to measure coping are the
Revised Ways of Coping Questionnaire (WOC-R) [5, 6]
and the Revised Ways of Coping Checklist (WCCL-R) that
derived from the WOC-R [7]. A previous meta-analysis
found several subscales from the WOC-R andWCCL-R were
associated with psychological and physical health outcomes
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in nonclinical adult samples, but greater use of seeking
social support (SSS) was the only subscale being associated
with poor physical health [8]. Individual studies showed
that greater use of SSS predicts readmission in patients
with coronary heart disease (CHD) [9], microalbuminuria
indicative of renal damage in black South African men [10],
and reduced stimulated lymphocyte proliferation indicative
of cell-mediated immune dysfunction in students [11].
The association between SSS and biological indicators of
health may depend upon the quality of the received support
[8]. Many of the studies considered in the above mentioned
meta-analysis were about relationship-related stressors such
as caregiving for a demented spouse. In that case SSS may
be distinct from receiving and ultimately perceiving social
support because the spouse cannot adequately provide social
support. However, it could also be that individuals who
ask for support are less healthy, whereby abundant research
shows that dementia caregivers have poorer mental and
physical health than noncaregiving controls [12]. The SSS
scale considers problem-focused (e.g., tangible assistance)
and emotion-focused (e.g., sympathy) strategies to interact
with others. High level of SSS could actually be maladaptive
when a caregiver seeks social support to vent his or her
emotional distress. A lack in perceived social support despite
high use of SSS might hinder stressed individuals to benefit
from the stress buffering effects of social support [13].
The overarching aim of this study was to further elucidate
the relationship between coping and biological indicators
of health. For this purpose we investigated the relationship
between coping strategies, assessed by the WCCL-R and cir-
culating biomarkers of cardiovascular health in a community
sample of elderly dementia caregivers and noncaregiving
controls. An investigation of these associations in the
elderly is clinically important since cardiovascular disease
(CVD) becomes more prevalent with aging, and elderly
dementia caregivers have a particularly increased risk of
developing CVD, particularly CHD [14–16]. We specifically
hypothesized that a greater use of SSS would be associated
with higher levels of circulating biomarkers that have been
linked to CVD, including elevated levels of proinflammatory
cytokines, acute phase reactants, cellular adhesionmolecules,
markers of endothelial dysfunction, and a prothrombotic
state [17, 18].
Increases in such biomarkers could be a function of
the type of the stressor (e.g., caregiving, low socioeconomic
status, life events, health-related problems) with which one
needs to cope and of the unique emotional (e.g., negative
affect), behavioral (e.g., exercise frequency), and physical
(e.g., sympathetic activation) responses to such a stressor. For
instance, if caregivers seek out for social support strongly,
but will not receive it, this might elicit depressed mood
that has been associated with a proinflammatory state
[19]. Thus, in several exploratory analyses, we also tested
whether (a) chronic stress, (b) affect, (c) health behavior,
and (d) autonomic activity would mediate or moderate the
relationship between coping styles and levels of circulating
biomarkers.
2. Methods
2.1. Study Participants. The University of California San
Diego (UCSD) Institutional Review Board approved the
study protocol and all participants provided written consent.
For the present study, we analyzed cross-sectional data
obtained at study entry of the UCSD “Alzheimer’s Caregiver
Study” investigating effects of dementia caregiving stress
on health of elderly spousal caregivers. Participants were
recruited through referrals from the UCSD Alzheimer’s
Disease Research Center, community support groups and
agencies serving caregivers, local senior citizen health fairs,
and referrals from other participants. Inclusion criteria were
being ≥55 years old, married, and dwelling in the com-
munity with a spouse. Exclusion criteria were presence of
any major illnesses (e.g., cancer), severe hypertension (BP >
200/120mmHg), or treatment with medication that were
known to affect biomarkers of interest (i.e., oral anticoag-
ulants, nonselective beta blockers, steroids). Caregivers had
to provide primary care for a spouse with a physician-
based diagnosis of Alzheimer’s disease. Noncaregivers were
recruited in the same communities to yield a gender- and
age-equated comparison group. By definition, spouses of
these noncaregivers did not require care for a serious medical
condition. Other exclusion criteria were as for caregivers
above.
Out of 186 enrolled subjects (126 caregivers, 60 non-
caregivers), 151 had complete data for the 12 assessed
biomarkers. One subject each missed data on coping, body
mass index (BMI), and dyslipidemia, and 12 subjects missed
data on norepinephrine (NEPI) levels. This yielded a sample
of 136 subjects (93 caregivers, 43 noncaregivers) with a
complete dataset for the present investigation allowing us to
compute full linear regression approach. The 45 subjects with
incomplete data did not significantly differ from the 136 sub-
jects with complete data for sociodemographic factors, CVD
risk factors, caregiving status, and ways of coping. All partic-
ipants were interviewed in their homes using questionnaires
to assess demographic factors, mood states, stressors, and
health status.
2.2. Sociodemographic, Health, and Psychometric Measures
2.2.1. Demographic Factors. We collected information on
gender, age, and years of education to define socioeconomic
status.
2.2.2. Body Mass Index. We asked participants for their
weight and height to calculate BMI.
2.2.3. Dyslipidemia. Plasma low-density lipoprotein choles-
terol (LDL-C) and high-density lipoprotein cholesterol
(HDL-C) were determined by standard methodology at the
clinical chemistry laboratories at the UCSD medical center.
We computed the LDL-C/HDL-C ratio with a higher ratio
indicating greater dyslipidemia.
2.2.4. Blood Pressure and Heart Rate. Using a noninvasive
Microlife blood pressure (BP) monitor, three BP and heart
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rate measurements were collected by the research nurse over
a 15-minute resting period. The participant’s mean systolic
resting BP was used for the analysis because it confers higher
CVD risk than diastolic BP in individuals over 50 years of age
[20].
2.2.5. Smoking Status. Smoking status was defined in terms
of ever (i.e., former plus current) smoker versus never
smoker (only one participant was a current smoker).
2.2.6. Health Problems. Participants were provided a list
with 17 health problems they might currently have or
that a doctor had informed them of having. Positive items
were added to one number of health problems. We also
formed separate categories for diabetes and any cardiovascular
disease that included myocardial infarction, congestive heart
failure, angina, additional heart diseases, and stroke (but not
systemic hypertension).
2.2.7. Alcohol Consumption. The amount of alcohol con-
sumption was assessed using a score that considered the
number of days subjects had at least one alcoholic drink and
the number of alcoholic drinks they usually drank on these
days considering the last month.
2.2.8. Physical Activity. The Rapid Assessment of Physical
Activity (RAPA) scale was used to assess the amount of
light, moderate, and strenuous physical activities, including
strength and flexibility exercises, in a typical week (total score
0–6) [21].
2.2.9. Sleep Quality. The Pittsburgh Sleep Quality Index
was used to assess subjective sleep quality, sleep duration,
sleep latency, sleep disturbances, sleep efficacy, use of sleep
medication, daytime dysfunction (global score between 0
and 21; higher scores indicate poorer sleep quality) [22].
2.2.10. Coping. Participants completed the WCCL-R [7] to
assess problem-focused coping (PFC; 15 items), seeking
social support (SSS; 6 items), blaming one’s self (BS; 3 items),
wishful thinking (WT, 8 items), and avoidance coping (AC,
10 items). Participants were asked to rate on a four point
scale the degree to which they used 42 coping strategies in
dealing with stressful situations that may arise in marriages
(0 = never used, 1 = used somewhat, 2 = used quite a bit,
3 = used a great deal). Typical strategies are “Got pro-
fessional help and did what they recommended” for PFC,
“Talked to someone to find out about the situation” for SSS,
“Blamed yourself” for BS, “Hoped a miracle would happen”
for WT, and “Avoided being with people in general” for AC.
2.2.11. Affect. We used the Positive and Negative Affect Scale
comprising 10 items per mood scale covering the past few
weeks on a 5-point scale (1 = very slightly or not at all, 5 =
extremely; total score between 10 and 50) [23].
2.2.12. Life Events. We used the Life Events Survey which
assesses how many of a list of 34 events had occurred to the
participant or a close relative or friend in the past year [24].
2.2.13. Social Support. The 8-item Social Support Scale was
used to assess help and support participants received from
friends and relatives [25]. Responses were rated on a 4-point
scale: 1 = strongly disagree, 4 = strongly agree; overall scores
were between 8 and 32.
2.2.14. Norepinephrine Levels. A highly sensitive catechol-o-
methyltransferase (COMT)-based radioenzymatic assay was
performed to determine plasma NEPI [26].
2.3. Biomarkers. Blood was collected in the participant’s
home at 10:30 AM. In order not to interfere with study
participants daily routine, fasting state was not a prerequisite
but was treated as a control variable. Plasma was stored
at −80◦C until analyzed. Concentrations of biomarkers
were determined in duplicates using commercially available
enzyme-linked immunosorbent assays per the manufactur-
ers’ instructions (Meso Scale Discovery, Gaithersburg, MD:
C-reactive protein (CRP), tumor necrosis factor (TNF)-α,
interleukin (IL)-6, IL-8, interferon (IFN)-γ, serum amyloid
A (SAA), soluble intercellular adhesion molecule (sICAM)-
1, soluble vascular cellular adhesion molecule (sVCAM)-
1; Quantikine, R&D Systems, Minneapolis, MN: endothelin
(ET)-1; Asserachrom Stago, Asnie`res, France: von Wille-
brand factor (VWF), plasminogen activator inhibitor (PAI)-
1, D-dimer).
We selected these 12 biomarkers because all of them are
variously involved in the initiation, progression, and clinical
manifestation of atherothrombotic CVD. They specifically
cover atherosclerotic processes related to inflammation
(proinflammatory cytokines: TNF-α, IL-6, IL-8, IFN-γ; acute
phase reactants: SAA, CRP), cellular adhesion (sICAM-
1, sVCAM-1), endothelial dysfunction (ET-1, VWF), and
thrombosis (PAI-1, D-dimer). A large body of literature
suggests that elevated circulating levels of these biomarkers
predict the risk of incident CHD as well as poor prognosis in
patients with established CHD [27–36].
2.4. Data Analysis. Data were analyzed using PASW 18.0
statistical software package (SPSS Inc., Chicago, IL, USA)
with P ≤ 0.05 (two-tailed). Normality of the distribution
of dependent variables (biomarkers) was verified using the
Kolmogorov-Smirnov test. Accordingly, IL-8, IFN-γ, SAA,
CRP, sICAM-1, ET-1, VWF, PAI-1, and D-dimer values were
all logarithmically transformed, and Blom normal scores
were computed for IL-6 and sVCAM-1 values. Pearson
correlation coefficients were calculated to estimate the
relation between two variables. Group comparisons used
independent t-test for continuous variables. Pearson χ2 test
and Fisher’s exact test, where appropriate, were conducted
for categorical measures.
To test for a relation between coping and biomark-
ers, we first employed multivariate analysis of covariance
(MANCOVA) to test whether each of the five coping scales
would be significantly associated with the group of the 12
biomarkers as a whole applying Bonferroni correction (P <
0.010 for 5 coping strategies). Control variables were selected
a priori as they may potentially affect biomarker levels:
age, gender, BMI, LDL-C/HDL-C ratio, systolic BP, smoking
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Table 1: Participant characteristics.
Variables All participants (n = 136) Caregivers (n = 93) Noncaregivers (n = 43) P
Age (years) 74.5± 7.7 74.6± 8.4 74.5± 6.2 0.937
Women (%) 67.6 67.7 67.4 0.972
Education (years) 15.4± 3.2 15.3± 3.1 15.5± 3.4 0.722
Body mass index (kg/m2) 26.4± 5.2 26.7± 4.9 25.9± 5.9 0.447
LDL-C/HDL-C ratio 2.2± 0.9 2.2± 0.8 2.2± 1.0 0.904
Systolic blood pressure (mmHg) 134± 15 135± 15 132± 15 0.432
Heart rate (beats/min) 66± 10 66± 10 66± 9 0.802
Ever smoker (%) 40.4 43.0 34.9 0.369
Diabetes (%) 9.6 12.9 2.3 0.062
Any cardiovascular disease (%) 14.7 19.4 4.7 0.035
Number of health problems 3.1± 1.8 3.5± 1.9 2.5± 1.4 0.001
Alcohol consumption (score) 5.4± 5.8 5.4± 5.7 5.5± 6.1 0.908
Rapid Assessment of Physical Activity (score) 3.6± 1.6 3.3± 1.6 4.1± 1.4 0.005
Pittsburgh Sleep Quality Index 6.1± 3.4 6.7± 3.5 4.8± 2.5 <0.001
Problem-focused coping (score) 22.2± 7.2 22.4± 6.8 21.9± 8.1 0.702
Seeks social support (score) 6.3± 4.2 6.9± 3.9 5.2± 4.5 0.027
Blamed self (score) 2.3± 1.9 2.3± 2.0 2.1± 1.8 0.626
Wishful thinking (score) 7.2± 4.8 7.8± 4.9 5.8± 4.3 0.020
Avoidance coping (score) 7.2± 4.0 7.5± 4.1 6.3± 3.6 0.098
Negative affect (score) 16.7± 6.3 17.9± 6.2 14.0± 5.7 0.001
Positive affect (score) 33.6± 7.5 31.8± 7.4 37.4± 6.4 <0.001
Number of life events 4.7± 3.3 5.0± 3.3 4.0± 3.1 0.108
Perceived social support (score) 26.6± 3.9 25.9± 3.9 28.0± 3.5 0.004
Fasting state (%) 15.4 12.9 20.9 0.307
Norepinephrine (pg/mL) 471± 210 472± 218 467± 193 0.885
Tumor necrosis factor-α (pg/mL) 5.76 (4.11–7.64) 5.79 (4.12–7.70) 5.41 (4.09–7.66) 0.603
Interleukin-6 (pg/mL) 1.12 (0.80–1.67) 1.07 (0.84–1.53) 1.30 (0.75–1.86) 0.189
Interleukin-8 (pg/mL) 6.91 (4.22–9.54) 6.88 (4.15–9.11) 7.07 (4.25–10.1) 0.267
Interferon-γ (pg/mL) 1.61 (0.96–2.39) 1.59 (1.06–2.41) 1.74 (0.80–2.29) 0.348
Serum amyloid A (mg/mL) 2.44 (1.13–7.39) 2.53 (1.14–7.30) 2.09 (1.01–8.06) 0.933
C-reactive protein (mg/mL) 1.42 (0.81–3.92) 1.49 (0.85–4.16) 1.24 (0.69–3.05) 0.422
Intercellular adhesion molecule-1 (ng/mL) 295 (217–489) 275 (208–486) 316 (224–490) 0.480
Vascular cellular adhesion molecule-1 (ng/mL) 541 (369–950) 545 (365–956) 539 (397–930) 0.842
Endothelin-1 (pg/mL) 1.10 (0.81–1.40) 1.08 (0.80–1.40) 1.15 (0.84–1.42) 0.514
von Willebrand Factor (%) 158 (83–270) 156 (92–269) 144 (75–287) 0.457
D-dimer (ng/mL) 630 (452–954) 671 (487–980) 613 (415–957) 0.300
Plasminogen activator inhibitor-1 (ng/mL) 25.9 (15.6–43.3) 29.1 (16.7–47.8) 21.1 (12.6–33.6) 0.149
Nonnormal distribution (even after log transformation)/all biomarkers (IVs) were log transformed/shown as median (IQR) Fischer Definition?
status, diabetes, any CVD, and fasting state. We further tested
for potential mediator and moderator variables (i.e., chronic
stress, affect, health behavior, autonomic activity) of the
relation between coping and individual biomarkers using
linear regression analysis. Linear independent variables were
centered at their means and binary variables were centered as
+0.5 and −0.5 [37]. Effect sizes from the regression models
are expressed as partial correlation coefficients (r). In case of
a significant interaction, we applied the Holmbeck method
to test whether high versus low levels in the moderator
variable, defined as +1 SD and −1 SD, respectively, would
alter the strength of the association between coping and
the biomarker [38]. A potential mediator was defined as an
independent variable that if added to a model would render
a significant relation between coping scales and biomarkers
nonsignificant. Cook’s distance was used to verify the absence
of outliers.
3. Results
3.1. Characteristics of Study Participants. Table 1 shows the
characteristics of study participants. Compared to noncar-
egiving control subjects, caregivers showed more CVD and
health problems, poorer sleep quality, and lower physical
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Table 2: Multivariate linear regression model for the relationship between seeking social support and individual biomarkers.
Entered variables
Interleukin-8 Serum amyloid A C-reactive protein Soluble VCAM-1 D-dimer
Partial corr. P value Partial corr. P value Partial corr. P value Partial corr. P value Partial corr. P value
Age 0.036 0.688 −0.001 0.989 0.041 0.649 0.124 0.164 0.368 <0.001
Female gender 0.078 0.385 0.142 0.111 0.167 0.061 −0.064 0.471 0.169 0.058
Body mass index 0.053 0.552 0.203 0.022 0.215 0.015 0.123 0.169 0.014 0.873
LDL-C/HDL-C ratio −0.017 0.846 −0.008 0.925 0.111 0.214 0.026 0.774 −0.006 0.951
Systolic blood pressure −0.065 0.469 0.158 0.077 0.175 0.049 0.067 0.4522 0.046 0.604
Ever smoker 0.016 0.860 0.009 0.924 0.062 0.492 −0.013 0.884 0.059 0.508
Diabetes 0.076 0.398 −0.078 0.381 −0.095 0.288 −0.113 0.207 0.015 0.867
Any cardiovascular disease −0.105 0.240 −0.076 0.395 −0.080 0.369 0.044 0.623 0.094 0.295
Fasting state −0.206 0.020 0.033 0.716 0.013 0.881 0.097 0.280 −0.051 0.566
Seeking social support −0.264 0.003 0.289 0.001 0.223 0.012 0.204 0.021 0.190 0.032
Model statistic
R2 = 0.139 R2 = 0.186 R2 = 0.189 R2 = 0.098 R2 = 0.227
F10,125 = 2.02, F10,125 = 2.86, F10,125 = 2.92, F10,125 = 1.36, F10,125 = 3.68,
P = 0.036 P = 0.003 P = 0.003 P = 0.209 P < 0.001
Partial corr.: partial correlation coefficient, significant P values are in bold.
activity. Caregivers also showed more negative affect, SSS,
and WT, but less perceived social support than noncare-
givers. There were no significant group differences in the
concentrations of any of the biomarkers. SSS and perceived
social support showed a direct but weak association (r =
0.18, P = 0.036).
3.2. Relationship between Coping Scales and Biomarkers as a
Group. We first performed MANCOVA to test for a signifi-
cant relationship between each of the five coping scales and
the group of 12 biomarkers as a whole. All analyses controlled
for age, gender, BMI, LDL-C/HDL-C ratio, systolic BP,
smoking status, diabetes, any CVD, and fasting state. We
found a significant relationship between SSS and the group of
biomarkers as a whole (F12,114 = 2.46, P = 0.007; partial η2 =
0.206). In contrast, there were no significant relationships
between the group of biomarkers and PFC (P = 0.058), BS
(P = 0.86), WT (P = 0.36), and AC (P = 0.47). In the
model for SSS, age (P < 0.001; partial η2 = 0.258), BMI
(P < 0.001; partial η2 = 0.262), and fasting state (P = 0.043;
partial η2 = 0.166) were also significantly related to the
entire group of biomarkers.
3.3. Relationship between Seeking Social Support and Individ-
ual Biomarkers. In MANCOVA, SSS showed significant rela-
tionships with IL-8 (P = 0.003), SAA (P = 0.001), CRP (P =
0.012), sVCAM-1 (P = 0.021), and D-dimer (P = 0.032).
The relationships with TNF-α (P = 0.45), IL-6 (P = 0.65),
INF-γ (P = 0.79), sICAM-1 (P = 0.065), ET-1 (P = 0.70),
VWF (P = 0.30), and PAI-1 (P = 0.22) were not significant.
The multivariate linear regression models for individual
biomarkers are shown in Table 2. Greater use of SSS was sig-
nificantly correlated with decreased levels of IL-8 (r = −0.26)
on the one hand and elevated levels of SAA (r = 0.29), CRP
(r = 0.22), sVCAM-1 (r = 0.20), and D-dimer (r = 0.19)
on the other. Of the covariates, greater age was significantly
associated with higher D-dimer, greater BMI was associated
with higher SAA and CRP, the latter also being directly
related to systolic BP. Participants who were assessed in the
fasting state had lower IL-8 than those assessed nonfasting.
3.4. Mediators of the Relation between Seeking Social Support
and Biomarkers. All meditational analyses were adjusted for
age, gender, BMI, LDL-C/HDL-C ratio, systolic BP, smoking
status, diabetes, any CVD, and fasting state. Chronic stress
(caregiving, socioeconomic status, life events, health prob-
lems), affect (negative affect, positive affect, perceived social
support), health behaviors (alcohol consumption, physical
activity, sleep), and autonomic activity (NEPI, heart rate)
did not emerge as significant mediators of the association of
SSS with IL-8, SAA, CRP, sVCAM-1, and D-dimer (data not
shown).
3.5. Moderators of the Relation between Seeking Social Support
and Biomarkers. All interaction effects were adjusted for
age, gender, BMI, LDL-C/HDL-C ratio, systolic BP, smoking
status, diabetes, any CVD, fasting state, SSS (main effect),
and the respective moderator variable (main effect).
Chronic Stress. There were significant interactions between
SSS and caregiver status for D-dimer (r = −0.19, P = 0.037)
and between the number of life events and IL-8 (r = 0.22,
P = 0.015). Greater use of SSS was associated with elevated
D-dimer levels in noncaregivers (r = 0.36, P = 0.036),
while SSS and D-dimer showed no association in caregivers
(r = −0.04, P = 0.75). Greater use of SSS was associated
with decreased IL-8 levels in subjects with a small number
of life events (r = −0.33, P < 0.001), whereas SSS and IL-8
showed no association in those with a high number of life
events (r = −0.07, P = 0.046). Socioeconomic status (years
of education) (P values > 0.26) and health-related stress (the
number of health problems) (P values > 0.20) did not both
emerge as moderator variables for any biomarker.
Affect. There were significant interactions between SSS and
positive affect for CRP (r = −0.11, P = 0.020) and between
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SSS and perceived social support for sVCAM-1 (r = −0.25,
P = 0.006). Greater use of SSS was associated with elevated
levels of sVCAM-1 in those with low levels of social support
(r = 0.32, P < 0.001), whereas no association emerged
between SSS and sVCAM-1 in those with high levels of social
support (r = −0.01, P = 0.89). In addition, greater use of
SSS was associated with elevated CRP levels in those with
low levels of positive affect (r = 0.30, P = 0.001), while SSS
showed no association with CRP in those with high levels of
positive affect (r = 0.03, P = 0.75). Negative affect did not
interact with SSS in predicting any biomarker (P-values >
0.52).
Health Behavior. There were no significant interactions
between SSS on the one hand and physical activity (P-values
> 0.45), alcohol intake (P values > 0.20), and sleep quality (P
values > 0.25) on the other for any biomarker.
Autonomic Nervous System Function. There was a significant
interaction between NEPI and SSS for IL-8 (r = −0.40,
P < 0.001). Greater use of SSS was associated with decreased
levels of IL-8 in subjects with high levels of NEPI (r = −0.46,
P < 0.001), whereas no association between SSS and IL-
8 was seen in those with low levels of NEPI (r = 0.10,
P = 0.27). Heart rate did not significantly interact with SSS
in predicting any biomarker (P values > 0.17).
4. Discussion
We found that greater use of SSS was associated with elevated
levels of several circulating biomarkers, all of which are proxy
measures of an increased risk of atherothrombotic CVD
in elderly community-dwelling subjects. This relationship
was independent of sociodemographic and CVD risk factors
that are known to affect biomarker levels. Specifically, we
found greater use of SSS to be associated with increased
levels of SAA, CRP, sVCAM-1, and D-dimer. We did not
find that PFC, BS, WT, and AC were significantly related to
biomarkers. The finding that greater use of SSS is associated
with elevated levels of biomarkers of atherothrombotic risk
is a novel one. Moreover, this observation is consistent with
a previous meta-analysis showing that greater use of SSS
was associated with negative physical health outcomes [8],
including a higher risk of hospital readmission in patients
with atherothrombotic CVD [9]. Greater use of SSS has
also been associated with a greater prevalence of microal-
buminuria [10], another risk factor for atherothrombotic
CVD. Although our cross-sectional data do not allow causal
inferences among the observed relationships, the pattern
of results is consistent with the notion that greater use of
SSS may increase atherothrombotic CVD risk. The finding
that greater use of SSS related to elevations in multiple
biomarkers strengthens the validity of the biological pathway
that may be implicated in SSS’s links to poor cardiovascular
health.
A variety of mechanisms might be involved in this
pathway. The acute phase reactant SAA is expressed by
human adipocytes and atherosclerotic lesions and may play a
critical role in local and systemic inflammation by linking
obesity and atherosclerosis [39]. CRP is also expressed
in the liver and in smooth muscle cells within diseased
atherosclerotic arteries. CRP has been implicated in multiple
aspects of atherogenesis. It particularly amplifies inflamma-
tory responses and induces expression of cellular adhesion
molecules (e.g., ICAM-1, VCAM-1), which mediate adhe-
sion of leukocytes to the vascular endothelium, as well as a
decrease in nitric oxide production, thereby promoting vas-
cular constriction [40]. Circulating concentrations of soluble
CAMs such as sVCAM-1 are markers of the inflammatory
cascade and of endothelial cell injury and dysfunction.
Soluble CAMs are actively involved in many of the stages of
atheroma development from initial leukocyte recruitment to
eventual rupture of the unstable atherosclerotic plaque [41].
In addition, the prothrombotic measure D-dimer indicates
coagulation activation and in vivo fibrin formation and lysis
in circulating blood, and its localization within the human
intima suggests it may have atherogenic properties [42].
To gain more insight into the mechanisms linking greater
use of SSS with biomarkers, we performed a series of
exploratory analyses in which we tested whether chronic
stress, affect, health behaviour, and autonomic activity might
possibly act as mediator or moderator variables. None of
these variables were suggested as mediators; however, there
may be other mediators that are relevant, but not tested in
our study. For instance, a life-time approach to experienced
psychosocial stress (i.e., considering stress burden for longer
than one year), inclusion of daily hassles, account of dietary
habits, and more thorough autonomic measures (e.g., heart
rate variability) might have also be important to investigate.
We found that the seemingly counterintuitive inverse
association between greater use of SSS and decreased levels
of the proinflammatory marker IL-8 was moderated by
life events and NEPI. Specifically, greater use of SSS was
associated with decreased IL-8 in subjects with few life
events, although it would seem that cardiovascular health
might particularly draw benefit from such an effect if life
stress is high.Moreover, greater use of SSS was also associated
with decreased IL-8 when NEPI levels were high. As NEPI
increases the IL-8 release from the endothelium [43], we
speculate that SSS interferes with NEPI-related IL-8 release
through a mechanism that remains to be elucidated. Of
equal interest were the moderating roles of positive affect and
perceived social support for CRP and sVCAM-1, respectively,
suggesting that greater use of SSS is particularly related to
increased atherothrombotic risk if factors of positive mental
health are low. Specifically, greater use of SSS was associated
with elevated CRP levels in subjects with low level of positive
affect (i.e., in those feeling desperate); this is in accordance
with the notion that positive affect is associated with
psychobiological processes that may be partly responsible
for the protective effects of positive affect on physical health
outcomes [44], including lower risk of incident CHD [45].
Moreover, greater use of SSS was associated with elevated
sVCAM-1 in subjects with low level of social support (i.e.,
in those feeling frustrated because not getting support in
spite of seeking it); this concurs with the concept of perceived
social support acting as a stress buffer [13], thereby reducing
the risk of incident CHD [46].
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These interaction effects suggest that help seeking is
not uniformly bad for cardiovascular health when assessed
through biomarkers, so elderly individuals clearly should not
be discouraged from seeking help. In fact, entire interven-
tions are based on the idea that for instance dementia care-
givers need to seek out additional support from their social
environment in order to better cope with caregiving burden
[47]. This might partially explain why there was no associa-
tion between SSS and D-dimer levels in caregivers, whereas
greater use of SSS was associated with elevated D-dimer
levels in noncaregivers. However, even though caregivers
reported greater use of SSS than noncaregivers, we found
little evidence that caregiver status substantially moderated
the association of greater use of SSS with elevated SAA, CRP,
and sVCAM-1 on the one hand and with decreased IL-8 on
the other. It is possible that copings styles other than SSS are
more important in not only maintaining but also impacting
on physical health in dementia caregivers. For instance, we
previously found that caregivers high in personal mastery
(i.e., a person’s belief that he/she can control the circum-
stances of his/her life) had less NEPI reactivity to acute men-
tal stress [48] but greater β2-adrenergic receptor sensitivity
indicative of better immune function over a followup of 5
years [49] compared to caregivers low in personal mastery.
From a clinical perspective, our data may imply that
encouragement of elderly individuals by clinicians about
seeking out support to possibly improve their cardiovascular
health needs to consider that not all friends and family
will be perceived as sources of support in which case
greater use of SSS might not be helpful if not harmful.
This might particularly be the case for those elderly low
in positive affect and low in perceived social support.
One recommendation could be that elderly individuals are
advised to disengage in time from seeking support from
certain members of their social network should they realize
they will not receive the expected amount and quality of
emotional and instrumental help. Whether such a strategy
would be effective in improving cardiovascular health might
be validated in an intervention study aimed at changing
coping behavior where a decrease in the use of SSS should
be associated with a concomitant decrease in SAA, CRP, and
D-dimer levels. However, these implications must consider
that the interactions between SSS and some covariates were
not observed for all biomarkers. Moreover, the number of
exploratory analyses conducted was substantial. Therefore,
the clinical conclusions and recommendations form these
secondary findings should be made with caution.
We discuss three limitations of our study. Firstly, cross-
sectional investigations capture only a snapshot of biobehav-
ioral processes. Coping processes are particularly actuated
when challenge occurs at which time biomarker response
would seem to be greatest. Therefore, experimental induc-
tion of acute stressful situations might be a more promising
way to investigate which coping styles are either functional
or dysfunctional in terms of moderating the stress response
of biomarkers. Secondly, biomarkers are intermediate end-
points of CVD. Although similar to that explained by age
and BMI, the variances in biomarkers that were explained
by SSS ranged 4–9%. Whether this effect size translates into
a clinically relevant increase in atherothrombotic CVD risk
needs to be seen in a longitudinal study. Thirdly, our results
stem from elderly with on average good physical and mental
health, two thirds of whom were dementia caregivers. Hence,
the findings may not be generalizable to younger populations
or elderly with greater prevalence of CVD and frailty.
5. Conclusions
The findings from our study suggest that elderly community-
dwelling individuals with increased use of SSS may have
elevated circulating levels of a range of biomarkers that have
been associated with an increased risk of atherothrombotic
CVD. Several moderating variables relating to the type
of chronic stress, affect, and sympathomedullary activity
need to be considered in this relationship. If replicated,
these results might offer promising avenues for interventions
focused on healthy coping strategies that might also improve
cardiovascular health in the elderly. These might include
provision of better practical and emotional support, as well
as cognitive-behavioral interventions to modify perceptions
of burden and support.
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